The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 07, 2018

Filed:

Oct. 20, 2017
Applicant:

Northwestern University, Evanston, IL (US);

Inventors:

Dimitri Krainc, Chicago, IL (US);

Richard B. Silverman, Winnetka, IL (US);

Jianbin Zheng, Evanston, IL (US);

Assignee:

Northwestern University, Evanston, IL (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 487/04 (2006.01); C12N 9/24 (2006.01); C07D 519/00 (2006.01); A61K 31/5377 (2006.01); A61K 31/519 (2006.01); C09B 11/24 (2006.01); A61K 38/46 (2006.01); A61K 9/00 (2006.01); A61K 9/10 (2006.01); A61K 9/02 (2006.01); A61K 9/20 (2006.01); A61K 9/12 (2006.01); A61K 9/48 (2006.01); A61K 31/5355 (2006.01); A61K 45/06 (2006.01); A61K 47/38 (2006.01); A61K 47/26 (2006.01);
U.S. Cl.
CPC ...
C07D 487/04 (2013.01); A61K 9/008 (2013.01); A61K 9/0019 (2013.01); A61K 9/02 (2013.01); A61K 9/10 (2013.01); A61K 9/12 (2013.01); A61K 9/20 (2013.01); A61K 9/2054 (2013.01); A61K 9/2059 (2013.01); A61K 9/48 (2013.01); A61K 9/4866 (2013.01); A61K 31/519 (2013.01); A61K 31/5355 (2013.01); A61K 31/5377 (2013.01); A61K 38/465 (2013.01); A61K 45/06 (2013.01); A61K 47/26 (2013.01); A61K 47/38 (2013.01); C07D 519/00 (2013.01); C09B 11/24 (2013.01); C12N 9/2402 (2013.01); C12Y 302/01045 (2013.01); G01N 2800/28 (2013.01);
Abstract

Disclosed are new small molecules having a 4-methylpyrrrolo[1,2-a]pyrimidine-8-carboxamide core structure and the uses thereof for modulating glucocerebrosidase activity. Also disclosed are pharmaceutical compositions comprising the small molecules which may be administered in methods of treating diseases or disorders associated with glucocerebrosidase activity, including neurological diseases and disorders such as Gaucher's disease and Parkinson's disease. The small molecules may contain a fluorophore or may be conjugated to a fluorophore in order to prepare a fluorescent probe for use in high throughput screening methods to identify new modulators of glucocerebrosidase activity via fluorescence polarization.


Find Patent Forward Citations

Loading…